This report presents the conceptual design of a new European research infrastructure EuPRAXIA. The concept has been established over the last four years in a unique collaboration of 41 laboratories within a Horizon 2020 design study funded by the European Union. EuPRAXIA is the first European project that develops a dedicated particle accelerator research infrastructure based on novel plasma acceleration concepts and laser technology. It focuses on the development of electron accelerators and underlying technologies, their user communities, and the exploitation of existing accelerator infrastructures in Europe. EuPRAXIA has involved, amongst others, the international laser community and industry to build links and bridges with accelerator science — through realising synergies, identifying disruptive ideas, innovating, and fostering knowledge exchange. The Eu-PRAXIA project aims at the construction of an innovative electron accelerator using laser- and electron-beam-driven plasma wakefield acceleration that offers a significant reduction in size and possible savings in cost over current state-of-the-art radiofrequency-based accelerators. The foreseen electron energy range of one to five gigaelectronvolts (GeV) and its performance goals will enable versatile applications in various domains, e.g. as a compact free-electron laser (FEL), compact sources for medical imaging and positron generation, table-top test beams for particle detectors, as well as deeply penetrating X-ray and gamma-ray sources for material testing. EuPRAXIA is designed to be the required stepping stone to possible future plasma-based facilities, such as linear colliders at the high-energy physics (HEP) energy frontier. Consistent with a high-confidence approach, the project includes measures to retire risk by establishing scaled technology demonstrators. This report includes preliminary models for project implementation, cost and schedule that would allow operation of the full Eu-PRAXIA facility within 8—10 years.
We describe a scheme for controlling electron injection into the quasilinear wakefield driven by a guided drive pulse via ionization of a dopant species by a collinear injection laser pulse with a short Rayleigh range. The scheme is analyzed by particle-in-cell simulations which show controlled injection and acceleration of electrons to an energy of 370 MeV, a relative energy spread of 2%, and a normalized transverse emittance of 2.0 μm.
We demonstrate experimentally the resonant excitation of plasma waves by trains of laser pulses. We also take an important first step to achieving an energy recovery plasma accelerator by showing that unused wakefield energy can be removed by an out-of-resonance trailing laser pulse. The measured laser wakefields are found to be in excellent agreement with analytical and numerical models of wakefield excitation in the linear regime. Our results indicate a promising direction for achieving highly controlled, GeV-scale laser-plasma accelerators operating at multi-kilohertz repetition rates. This article was published in Physical Review Letters 119, 044802 on 27 July 2017. DOI: 10.1103/PhysRevLett.119.044802 Copyright 2017 American Physical Society
The generation of GeV-scale electron beams in a gas-filled capillary discharge waveguide with good reproducibility is discussed. Beams of electrons with energies above 900 MeV, and with root-mean-square divergences of 3.5 mrad, are observed for a plasma density of 2.2 × 10 18 cm −3 and a peak input laser power of 55 TW. The variation of the maximum electron energy with the plasma density is measured and found to agree well with simple models. Injection and acceleration of electrons at the to date lowest plasma density of 3.2 × 10 17 cm −3 are reported. The energy spectra of the generated electron beams exhibit good shot-to-shot reproducibility, with the observed variations attributable to the measured shot-to-shot jitter of the laser parameters. Two methods for correcting the effect of beam pointing variations on the measured energy spectrum are described.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.